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Major depressive disorder (MDD) is among the most disabling 
mental disorders worldwide (World Health Organization, 2017), 
imposing an enormous social and fi nancial burden on society 
(Friedrich, 2017). In Spain, in addition to the fi nancial and 
societal costs, this is the leading cause of disability as measured 
in quality-adjusted life years (QALY) in (Ruiz-Rodríguez et 
al., 2017) and is highly prevalent in the Spanish primary care 
(PC) setting (Muñoz-Navarro et al., 2017a; Roca et al., 2009). 
Moreover, greater presence of MDD results in higher levels of 
disability and less quality of life (González-Blanch et al., 2018a; 
2018b). Unfortunately, MDD is underdiagnosed and undertreated 
in the Spanish national health care system (Fernández et al., 
2010). Consequently, there is an urgent need to improve early 
detection and to shorten the time between detection and referral 
to appropriate care. 
The use of brief screening tests in the PC setting is a cost-
effective and effi cient approach to detect patients with suspected 
depression. The Patient Health Questionnaire (PHQ-9) (Kroenke, 
Spitzer, & Williams, 2001) is the most widely-used screening 
tool to assess depression and depressive symptoms in primary 
care (Mitchell, Yadegarfar, Gill, & Stubbs, 2016). This tool was 
recently validated by Muñoz-Navarro et al. (2017a) for use in 
Spanish primary care centres. That validation study showed that a 
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Abstract Resumen
Background: Major depressive disorder (MDD) is highly prevalent in the 
Spanish primary care (PC) setting and the leading cause of disability in 
Spain. The aim of this study was to evaluate several key psychometric 
properties of the Sheehan Disability Scale (SDS) in patients with or 
without MDD and varying degrees of symptom severity using the Patient 
Health Questionnaire-9 (PHQ-9). Method: A total of 1,704 PC patients 
participating in the PsicAP clinical trial completed the SDS and PHQ-9. 
We evaluated the factor structure, measurement invariance across gender, 
internal consistency, and the discriminative and predictive validity. 
Results: Confi rmatory factor analyses revealed a unifactorial model of the 
SDS containing 4 items (SDS-4) with the best model fi t (CFI: .99; GFI: .99; 
TLI: 96; RMSEA: .10). This model contained the three life domain items 
(work, family, and social life) plus perceived stress (PS) with signifi cant 
loadings. The internal consistency of the SDS-4 was acceptable in patients 
with or without MDD, regardless of symptom severity. The SDS-4 also 
showed good discriminative capacity and acceptable predictive validity in 
all subsamples. Conclusions: These fi ndings support the use of the SDS-4 
to assess depression-related disability in patients at Spanish primary care 
centres.
Keywords: Disability, perceived stress, primary care, major depression, 
depressive symptoms.
Discapacidad y estrés percibido en pacientes de atención primaria con 
depresión mayor. Antecedentes: el Trastorno Depresivo Mayor (TDM) 
es muy prevalente en la atención primaria (AP) española y es la principal 
causa de discapacidad en España. En este trabajo se estudiaron algunas 
propiedades psicométricas de la Escala de Discapacidad de Sheehan 
(SDS) en pacientes con o sin TDM y con varios niveles de severidad 
de síntomas, usando el Patient Health Questionnaire-9 (PHQ-9). 
Método: 1.704 pacientes de AP que participaron en el ensayo clínico 
PsicAP cumplimentaron la SDS y el PHQ-9. Se estudió la estructura 
factorial, medida de invarianza de género, consistencia interna, validez 
discriminativa y la validez predictiva. Resultados: el análisis factorial 
confi rmatorio mostró un modelo unifactorial con 4 ítems (SDS-4) con 
un buen ajuste (CFI: .99; GFI: .99; TLI: 96; RMSEA: .10). Este modelo 
contenía los tres ítems de esferas de la vida (trabajo, familia y vida social) 
más el ítem de estrés percibido con cargas signifi cativas. La consistencia 
interna de la SDS-4 fue aceptable en pacientes con MDD y con diferente 
severidad de síntomas depresivos. También se halló una buena validez 
discriminativa y aceptable validez predictiva. Conclusiones: nuestros 
hallazgos respaldan el uso de la SDS-4 cuando se evalúe la discapacidad 
relacionada con la depresión en centros de AP españoles.
Palabras clave: discapacidad, estrés percibido, atención primaria, depresión 
mayor, síntomas depresivos.
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cut-off score of 12 on the PHQ-9 yields an acceptable sensitivity 
and specifi city (.84 and .78, respectively). Similarly, the PHQ-9 
used as a diagnostic algorithm also showed an acceptable 
sensitivity (.88) and specifi city (.80). The fi ndings of another 
recent study supported the plausibility of a unifactorial, invariant 
model across gender and various sociodemographic variables 
in a large (n=1250) Spanish primary care sample (González-
Blanch et al., 2018c). These studies confi rm the reliability of 
the PHQ-9 in the PC setting. However, to detect the presence of 
clinical depressive symptoms, it is essential to also check for the 
presence of impairment and disability. Given that disability and 
depressive symptoms do not necessarily present simultaneously, 
it is important to detect and treat both components, especially in 
primary care (Luciano et al., 2010). 
According to the World Health Organisation (WHO, 2019), 
disability is a physical or mental condition that limits an 
individual’s ability to perform common activities of daily living. 
Although there are many domains of disability, depression-
related disability has been mainly associated with functional 
and social domains. One of the most widely used measures to 
assess these disability domains in the primary care setting is the 
Sheehan Disability Scale (SDS) (Sheehan, Harnett-Sheehan, & 
Raj, 1996), due to its shortness. The SDS is a fi ve-item instrument 
that measures the severity of disability as the degree of functional 
impairment on three inter-related life domains in one single 
factor—work, family, and social life-plus two additional items 
to assess perceived stress (PS) and social support (SS) that work 
indpendently. The majority of psychometric studies conducted 
in PC settings to examine depression (Leon, Shear, Portera, & 
Klerman, 1992; Leon, Olfson, Portera, Farber, & Sheehan, 1997; 
Luciano et al., 2010) and in other settings and health conditions 
(Arbuckle et al., 2009; Hambrick, Turk, Heimberg, Schneier, 
& Liebowitz, 2004; Hodgins, 2013) have consistently found a 
factor structure consisting of only three-items (work, family, 
and social life), while the other two items (PS and SS) provide 
additional information but are not included in the factor structure. 
The SDS was validated for administration in Spain by Bobes et 
al. (1999), who found an acceptable internal consistency for the 
life domain factor (α = 0.72), convergent validity (r = 0.35 – 
0.52), and a high test-retest reliability (r = 0.87). However, the 
single items (PS and SS) yielded worse results. To date, only one 
study has evaluated the psychometric properties of the SDS in 
the Spanish PC setting (Luciano et al., 2010). Consistent with 
previous studies, that study also found a one-dimensional factor 
containing the three life domains items with the PS and SS as 
independent items. The one-dimensional factor presented good 
internal consistency (α = 0.83) and good discriminative validity 
for detecting MDD (sensitivity = 81.6%,  specifi city = 70.6%). To 
our knowledge, no studies have yet evaluated the psychometric 
properties of the fi ve-item SDS. This is an important gap in 
the literature given previous research suggesting the need to 
evaluate different models that assess the dimensionality of items 
that assess latent factors (Muñiz & Fonseca-Pedrero, 2018). 
Therefore, the objective of the present study, carried out in 
primary care centres in Spain, was to evaluate the factor structure, 
measurement invariance across gender, internal consistency, and 
discriminative and predictive validity of the SDS in a sample of 
patients with or without depression and with varying levels of 
symptom severity. 
Method
Participants
A total of 1,704 patients were recruited between January, 
2014 and May, 2017 from 28 PC centres involved in the PsicAP 
study (Cano-Vindel et al., 2016). The PsicAP is a randomized 
controlled trial being conducted to test the effi cacy of group 
transdiagnostic cognitive-behavioral therapy versus treatment as 
usual for emotional disorders in the PC setting in Spain. Of these 
1704 patients, 78.6% were women and 21.4% men. The mean 
age was 43.6 (± 12.3) years (range, 16 - 80). Table 1 shows the 
sociodemographic data for the sample. 
Instruments
Sheehan Disability Scale (SDS). The SDS is a fi ve-item tool 
that measures disability severity using an analogue visuo-spatial 
scale with numeric and verbal descriptive anchors (Sheehan et 
al., 1996). It contains a single total disability factor containing the 
Table 1
Demographic characteristics of sample
 
Total sample
(n = 1704)
N %
Gender 
Female
Male
1340
364
78.6
21.4
Age group, years 
≤ 19
20 - 39
40 - 59
≥ 60
27
609
912
156
1.6
35.7
53.5
9.2
Marital status
Married
Divorced
Widowed
Separated
Never married
Unmarried 
790
154
55
87
358
260
46.4
9.0
3.2
5.1
21.0
15.3
Level of education
No schooling
Basic education
Secondary education
High School
Bachelor
Master/doctorate
25
432
371
434
366
76
1.5
25.4
21.8
25.5
21.5
4.5
Employment status
Employed part-time
Employed full time
Unemployed, in search of work
Unemployed, not looking for work
Temporary incapacity to work
Permanent incapacity to work
Retired
639
250
367
205
129
38
76
14.7
37.5
21.5
12.0
7.6
2.2
4.5
Income
< 12,000 €
12,000 - 24,0000€
24,000 - 36,000€
> 36,0000€
673
697
221
113
39.5
40.9
13.0
6.6
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fi rst three items, which measure three inter-related life domains; a) 
working life; b) family life; and c) social life, plus two additional 
items that assess perceived stress and social support. For the fi rst 
four items, patients rate the extent to which their symptoms impair 
the domain of interest using a 10-point Likert scale (0 = ‘Not at 
all, 5 = ‘Moderately, 10 = ‘Extremely). The total disability total 
score ranges from 0 (unimpaired) to 30 (highly impaired). Scores 
for the PS range from 0-10 while the SS is scored from 0% to 
100%. Higher values on the PS refl ect greater stress whiles higher 
percentages on the SS indicate greater social support. The Spanish 
version validated by Bobes et al. (1999) was used for this study.  
Patient Health Questionnaire-9 (PHQ-9). The PHQ-9 (Kroenke 
et al., 2001) is the depression module of the PHQ containing the 
nine DSM-IV items used to diagnose major depressive disorder 
(MDD). The scale is designed to detect the presence of the 
following symptoms over the previous two weeks: (a) anhedonia; 
(b) depressed mood; (c) sleep problems; (d) feelings of tiredness; 
(e) changes in appetite or weight; (f) feelings of guilt; (g) diffi culty 
concentrating; (h) feelings of worry; and (i) suicidal ideation. 
Responses are given on a four-point Likert scale ranging from 0 
- 3 as follows: 0 (never), 1 (several days), 2 (more than half of 
the days), and 3 (most days). The total score thus ranges from 0 
to 27. The PHQ-9 can be used to diagnose MDD using a specifi c 
coding algorithm based on the DSM-IV criteria. For this diagnosis, 
at least one of the two fi rst symptoms (i.e., items) must have a 
score ≥ 2 and four of the remaining items must also receive a 
score ≥ 2 (with the exception of item 9 [suicide], in which a rating 
of 1 is suffi cient). The PHQ-9 also rates symptom severity, as 
follows: 0-4 (no symptoms); 5-9 (mild); 10-14 (moderate); 15-19 
(moderately severe); and 20-27 (severe). The Spanish version of 
this module validated for use in Spanish primary care centres was 
used (Muñoz-Navarro et al., 2017a). 
Procedure
General practitioners involved in the PsicAP trial invited 
patients with a suspected emotional disorder (anxiety, depression, 
or somatisation) to participate. All participants were provided with 
a patient information sheet containing full details about the study 
purpose. Signed informed consent was required for participation 
in the study. Patients who agreed to participate were scheduled to 
meet with a clinical psychologist, at which time they completed 
various computerized measures. The study was conducted in 
accordance with the principles of the Declaration of Helsinki and 
with the Spanish Law on Data Protection. It was approved by the 
Clinical Research Ethics Committee of primary care in Valencia, 
Spain (CEIC-APCV) and the Spanish Agency of Medicines and 
Medical Devices (AEMPS) (EUDRACT: 2013-001955-11 and 
Protocol Code: ISRCTN58437086). 
Data analysis
Factor structure 
The SPSS v.26 software program and the Amos module were 
used to perform the statistical analyses. A confi rmatory factor 
analysis (CFA) was performed to test the fi t of four different 
models, as follow: 1) Model 1 (SDS-3), a unidimensional factor 
containing the three items of the total disability factor; 2) Model 
2 (SDS-4), a unidimensional factor containing the total disability 
factor plus the PS item; 3) Model 3 (SDS-5), a unidimensional 
factor containing all fi ve items; and 4) Model 4, a bidimensional 
model with 2 factors: factor 1 contained the three items of the 
total disability factor and factor 2 contained the other two items 
(PS and SS). Confi rmation of the adequacy of these models was 
performed by determining absolute fi t indices using the chi-square 
statistic (x2) and the ratio among degrees of freedom (values < 2 
are recommended). We assessed the goodness-of-fi t (GFI) indices 
and the comparative fi t index (CFI) to assess incremental fi t. CFI 
and GFI values range from 0 and 1, with a reference value of 0.90 
(Hu & Bentler, 1998). Finally, the error of the root mean square 
approximation (RMSEA) was calculated. For this index, smaller 
values indicate better fi t, ranging from 0.05 to 0.10. Differences 
between the models were assessed by comparing the x2 values to 
check for signifi cance. 
Measurement invariance for gender
Analyses of multiple-group invariance were conducted 
to determine the extent to which the factor structure was 
comparable across gender. Four levels of measurement invariance 
were sequentially tested (confi gural, weak, strong, and strict 
invariance), where each level introduced more equality constraints 
across groups. The fi t of the restricted model (equal factor loadings 
across groups) and the free model were compared in terms of 
their x2 values. A non-signifi cant increase in the x2 value (relative 
to df) in the constrained model relative to the unconstrained 
model indicated that the constraints across groups were possible. 
As an additional criterion, the change in the CFI coeffi cient was 
considered. If the drop in CFI of the constrained model relative 
to the unconstrained model did not exceed 0.01, the constrained 
model was accepted.
Internal consistency
A univariate descriptive data analysis was performed to explore 
how the variables were presented. We assessed the characteristics 
of the items, and calculated the means, standard deviations 
(SD), and item-total correlations for each item on the SDS and 
the PHQ-9. Internal consistency was evaluated using the ordinal 
Cronbach’s omega (ω) for the SDS and Cronbach’s alpha (α) for 
the PHQ-9. The average variance extracted (AVE) and composite 
reliability (CR) were also tested. Data from the SDS regarding 
the presence or not of major depression (based on the PHQ-9 
diagnostic algorithm) are described, together with the depressive 
symptoms and severity (based on the following PHQ-9 range for 
symptom severity: no symptoms, mild, moderate, moderately 
severe, or severe symptoms). 
Discriminative validity
A one-way analysis of covariance (ANCOVA) was implemented 
to determine whether or not differences in 1) the presence or not 
of depression and 2) the severity of depressive symptoms had an 
impact on the degree of disability and on the SS score. The post 
hoc comparisons were adjusted using Bonferroni correction (alpha 
level for the post hoc tests was set at 0.05). Effect sizes (Cohen’s d) 
were also determined. For symptom severity, the effect sizes were 
compared with the previous symptoms sample to determine the 
effect on an increase in symptom severity. 
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Predictive validity of the SDS to detect major depression and 
depressive symptoms
We conducted a receiver operating characteristic (ROC) curve 
analysis to determine the area under the curve (AUC) and the 
range of cut-off scores for the SDS to assess the utility of the scale 
to discriminate between patients with and without MDD and to 
discriminate between patients with different levels of symptom 
severity. We also calculated the sensitivity, specifi city, positive and 
negative predictive value, positive and negative likelihood ratios 
and the Youden’s Index (J).
Results
Factor structure analysis
Table 2 present the CFA results for all models. Model 2 
presented a good fi t (x2 = 40.06; p < 0.05; CFI = 0.99; IFI = 0.99; 
and RMSEA = 0.10). Model 2 (SDS-4) is a unifactorial model 
containing four items: the three life domains (work, family, and 
social life) plus the PS. Model 3 (SDS-5) also presented a good 
model fi t. However, the SS item did not present a signifi cant factor 
loading, suggesting that model 2 ( SDS-4) is the best model fi t. No 
differences between models were found. See Table 2 and Figure 1 
for more information about model fi t. 
Measurement invariance across gender
To determine whether gender affected the measurement model, 
the sample was divided into males and females and constraints were 
introduced to test if the parameters could be constrained across both 
groups. Both models were compared in terms of ∆x2 and by ∆CFI. All 
levels of invariance up to strict invariance could be assumed across 
gender, as evidenced by a non-signifi cant drop in model fi t (∆CFI 
0.01) for the successively more constrained models. See Table 3.  
Internal consistency
After obtaining the one-factor solution (SDS-4) described 
above, we performed several descriptive analyses to evaluate 
the internal consistency of this SDS-4. Scores on this four-item 
scale range from 0-40, with a mean (SD) of 18.4 (10.4); corrected 
item–total correlations ranged from 0.56 to 0.67. The mean SS 
score was 53.23 (32.74), with a corrected item–total correlation 
of 0.042, indicating a low correlation with the other items. Internal 
consistency for the SDS-4 was acceptable (ω = 0.84), with a good 
AVE (0.86) and CR (0.93). The mean score for the PHQ-9 items 
was 13.3 (8.2). The corrected item–total correlations ranged from 
0.52 to 0.73 on this scale, with very good internal consistency (α 
= 0.87). 
Mean PHQ-9 scores as a function of depressive diagnosis
In patients who met PHQ-9 criteria for MDD, the mean (SD) 
scores on this tool were 19.0 (3.72), compared to 8.40 (3.72) for 
those without a diagnosis of MDD. This difference was signifi cant 
on the one-way ANCOVA [F(1,1) = 3438.95; p < 0.0001]. On the 
post hoc analysis, patients with MDD scored signifi cantly higher 
on the PHQ-9 than patients without MDD with a large effect size 
(d = 2.84). See Table 4 for more details.  
Mean PHQ-9 scores according to depressive symptom severity
Mean PHQ-9 scores presented signifi cant differences for all 
symptom severity categories [F(1,4) = 6557.137; p < 0.0001], with 
greater severity associated with higher PHQ-9 scores and very 
large effect sizes ( > 3) when symptom severity was compared 
with previous symptoms. Table 4 shows all values. 
Discriminative validity of the SDS-4 in patients with and without 
MDD
The mean scores on the SDS-4 were evaluated in patients with 
and without MDD using the PHQ-9 diagnostic algorithm. As Table 
6 shows, the mean (SD) SDS-4 values were 23.4 (9.3) for patients 
with MDD versus 14.15 (9.3) in those without MDD. Post hoc 
analyses of the ANCOVA conducted to compare the two groups 
showed that these differences were signifi cant [F (1,1) = 417.313; 
p < 0.0001]. Patients with MDD had signifi cantly higher disability 
scores on the SDS-4 than patients without MDD, with a large 
effect size (d = 0 .99). The internal consistency of the PHQ-9 for 
the SDS-4 was acceptable for patients with MDD (0.77) and good 
for patients without a diagnosis of depression (0.83). See Table 4 
for more details. 
Discriminative validity of the SDS-4 in patients with MDD and 
different degrees of symptom severity 
We found that SDS-4 scores increased as a function of symptom 
severity [F(1,4) = 173.516; p < 0.0001]. Post hoc analyses showed 
that there were signifi cant differences at all levels, indicating 
that patients with more severe depressive symptoms presented 
greater disability. In this case, medium effect sizes were found 
when disability scores where compared with previous symptoms. 
Internal consistency ranged from acceptable to good (0.74-0.81). 
All values for the SDS-4 are shown in Table 4. 
Table 2
CFA adjustment indices
χ² df CFI GFI TLI RMSEA (90% IC) χ²dif AIC
Model 1 (3 items) 174.70* 2 0.94 0.94 0.86 0.23 (.19 - .25) 182.70
Model 2 (4 items) 40.06* 2 0.99 0.99 0.96 0.10 (.08 - .14) 134.64 56.06
Model 3 (5 items) 58.93* 5 0.98 0.99 0.96 0.08 (.06 - .10) 115.77 78.93
Model 4 (2 factors) 39.08* 4 0.98 0.99 0.96 0.08 (.06 - .10) 135.62 61.08
* p<0.05
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Figure 1. Models fi tness and representation
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Relationship between the SS item, depression diagnosis, and 
symptom severity. 
Patients without MDD on the PHQ-9 had a mean (SD) score 
on the SS item of 54.9 (32.7) versus 51.3 (32.7) in those who met 
PHQ-9 criteria for MDD, with a signifi cant difference (one-way 
ANOVA: [F(1,1) = 3.373; p < 0.05]). Post hoc analyses showed 
that patients with MDD reported less social support than patients 
without MDD, but with a low effect size (d = - 0.11). In terms of 
the association between SS item scores with different symptom 
severity levels, we found no signifi cant differences within any 
level (p > 0.05). See Table 4 for more details. 
Predictive validity of the SDS-4 to discriminate for major 
depression
The accuracy of the SDS to discriminate between cases with 
and without MDD was acceptable (AUC = 0.76, standard error 
(SE) = 0.012, P < 0.0001, 95% CI, 0.73–0.78). Based on the ROC 
analysis, a cut-off score of 19 yielded the best trade-off between 
sensitivity and specifi city (Youden’s index) for the SDS-4 (J = 
0.39). Also, a cut-off score of 16 also yielded a good Youden’s 
index for the SDS-4 (J=0.38). See in table 5 all the values of 
sensitivity, specifi city, positive and negative predictive values, and 
positive and negative likelihood ratios. 
Predictive validity of the SDS-4 to discriminate for mild depressive 
symptoms
On the ROC analysis, the AUC of the SDS-4 was 0.83 (SE = 
0.017; P <0 .0001; 95% CI, 0.80–0.86), indicating a good capacity 
to detect mild depressive symptoms. The best Youden’s index 
score (J = 0.52) suggested a score of 12 as the optimal cut-off point 
but also a cut-off score of 9 yielded a good Youden’s index for the 
SDS-4 (J = 0.50). Table 6 shows other possible cut-off points and 
CIs. 
Predictive validity of the SDS-4 to discriminate for moderate 
depressive symptoms
The ROC analysis showed that the AUC of the SDS was 0.78 (SE 
= .012, P < .0001, 95% CI, 0.76–0.81), indicating a good capacity 
to detect moderate depressive symptoms. The best Youden’s index 
(J = .44) suggested a cut-off score of 16 as the optimal cut point but 
a cut-off score of 14 offered a good Youden Index for the SDS-4 
(J = .43). All differences in this ROC values can be observed in 
Table 7.
Predictive validity of the SDS-4 to discriminate for moderately 
severe depressive symptoms
The AUC for the SDS was 0.77 (SE = 0.011, P < 0.0001, 95% 
CI 0.74-0.79), indicating a good capacity to detect moderately 
Table 3
Gender Invariance of the SDS-4
χ² df CFI TLI RMSEA ΔCFI Δ χ² Δ df
Confi gural Invariance 41.94 4 0.98 0.96 0.075 – – –
Weak Invariance 42.79 7 0.98 0.97 0.055 0.00 0.85 3
Strong Invariance 42.80 8 0.98 0.98 0.051 0.00 0.01 1
Strict Invariance 59.95 12 0.98 0.98 0.048 0.00 17.15 4
Table 4
Values for discriminative validity according presence or not of MDD and different severity symptoms
PHQ-9 SDS-4 SS item
PHQ-9 criteria n M SD p d M SD α p d M SD p d
PHQ-9 without major depression 914 8.40 3.72 14.2 9.3 0.83 54.9 32.7
PHQ-9 with major depression 790 19.00 3.72 0.0001 2.84 23.4 9.3 0.77 0.0001 0.99 51.3 32.7 .04 -0.11
PHQ-9 without symptoms (0-4) 150 2.7 1.32 7.6 7.6 0.81 56.8 35.8
PHQ-9 mild symptoms (5-9) 394 7.2 1.35 0.0001 3.33 13.0 8.7 0.81 0.0001 0.64 56.4 32.7 n.s -0.01
PHQ-9 moderate symptoms (10-14) 426 11.9 1.44 0.0001 3.41 17.9 8.6 0.75 0.0001 0.57 52.2 31.3 n.s -0.13
PHQ-9 moderate severe symptoms (15-20) 513 17.7 1.93 0.0001 3.39 22.8 9.3 0.78 0.0001 0.55 52.0 32.0 n.s -0.01
PHQ-9 severe symptoms (21-27) 221 23.8 1.62 0.0001 3.25 26.4 8.7 0.74 0.0001 0.40 49.9 34.4 n.s -0.06
Table 5
Operational characteristics of the SDS for major depression
Cut-off score SE SP + PV - PV + LR - LR J
SDS-4 ≥ 15 0.79 0.56 0.61 0.76 1.79 0.56 0.35
SDS-4 ≥ 16 0.77 0.61 0.63 0.75 1.96 0.51 0.38
SDS-4 ≥ 17 0.74 0.63 0.63 0.74 2.01 0.50 0.37
SDS-4 ≥ 18 0.70 0.67 0.65 0.72 2.11 0.47 0.37
SDS-4 ≥ 19 0.68 0.70 0.67 0.72 2.30 0.43 0.39
SDS-4 ≥ 20 0.63 0.74 0.68 0.70 2.44 0.41 0.37
Abbreviations: Sensitivity (SE), specifi city (SP), positive predictive value (+ PV) and 
negative predictive value (- NP), positive likelihood ratios (+ LR) and negative likelihood 
ratios (- LR) and the Youden’s Index (J)
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severe depressive symptoms. The best Youden’s index (J=0.39) 
suggested a cut-off score of 19 as the optimal cut-off point for the 
SDS-4, but a cut-off score of 16 on the SDS-4 provided an equally 
good Youden’s index (J=0.39). See Table 8 for other possible cut 
points and CIs. 
Predictive validity of the SDS-4 to discriminate for severe 
depressive symptoms
On the ROC analysis, the AUC for the SDS-4 was 0.75 (SE = 
0.017, P < 0.0001, 95% CI 0.72–0.79), indicating a good capacity 
to detect severe depressive symptoms. The best Youden’s Index (J 
= 0.38) suggested a cut-off score of 19 and 22 on the SDS-4. Table 
9 shows the differences between ROC values in this provided 
scores and other possible cut-off points. 
Discussion 
This study shows that the best model fi t for the SDS was model 
2, which was comprised of a 4-item scale (SDS-4) that included 
the assessment of perceived stress. Although model 3 presented 
a slightly better fi t, SS did not signifi cantly load on the model. 
Consequently, SS was not included in the model but could be 
administered as an adjunct to assess perceived social support. The 
4-item SDS model differs from most previous studies, which have 
consistently found a unifactorial structure containing only the three 
life domain items (work, family, and social life) while the other two 
items are considered independent (Arbuckle et al., 2009; Hambrick 
et al., 2004; Hodgins, 2013; Leon et al., 1992; Leon et al., 1997; 
Luciano et al., 2010). For instance, Luciano et al. (2010) found a 
good model fi t for the three-item scale in Spanish primary care, 
except for the chi-squared GFI statistic, which was statistically 
signifi cant. By contrast, we found that the addition of PS in this 
disability assessment tool yielded a good model fi t; moreover, this 
model was invariant across gender, further supporting its value in 
the primary care setting in Spain and, potentially, other regions.
In the PC setting, the prevalence of depression increased due to the 
lingering effects of the global fi nancial crisis that began in 2008/2009, 
especially among individuals who perceive social instability as 
a stressor (Navarro-Mateu et al., 2015). A large body of research 
has associated stress with depression and/or burnout (Bianchi, 
Schonfeld, & Laurent, 2015), suggesting that perceived stress should 
be evaluated and considered in the context of treating mental health 
disorders. This is especially important because an impaired cognitive 
capacity to manage stress could be a barrier to emotional wellbeing 
(Puigbó, Edo, Rovira, Limonero, & Fernández-Castro, 2019). 
In terms of internal consistency, the SDS-4 presented a good 
Ordinal Cronbach’s alpha (ω = 0.84). In addition, when the sample 
was divided into groups according to the presence or not of MDD 
or categorized by symptom severity, the SDS-4 had a good internal 
consistency for all levels. The SDS-4 was acceptable with a good 
discriminative capacity for all symptom severity levels. All these 
fi ndings further support the use of the SDS-4 version. 
When we compared patients with and without MDD (PHQ-9 
diagnostic algorithm), we found that patients with MDD scored 
signifi cantly higher on the SDS-4 (medium effect size). Scores on 
the SDS-4 also increased as a function of greater symptom severity 
(medium effect sizes) when compared to previous symptoms. 
Moreover, the mean PHQ-9 scores were higher in patients with 
more severe depressive symptoms (see Table 4), a fi nding that is 
consistent with previous research (Luciano et al., 2010; Mitchell 
et al., 2016). 
The mean scores on the SDS-4 were higher in patients with 
MDD versus those without, indicating a greater level of disability. 
This fi nding held true for all levels of symptom severity. Overall, 
these fi ndings support previous research suggesting that patients 
with depression who have greater impairment and greater symptom 
severity have more disability (Friedrich, 2017; World Health 
Organization, 2017). By contrast, patients without depression 
reported more social support than patients with depression, but 
with a very low effect size. We found no association between 
symptom severity and the degree of social support, suggesting that 
perceived social support had no effect on symptom severity. 
Table 6
Operational characteristics of the SDS for mild depressive symptoms
Cut-off score SE SP + PV - PV + LR - LR J
SDS-4 ≥ 8 0.84 0.65 0.96 0.27 2.36 0.42 0.48
SDS-4 ≥ 9 0.81 0.69 0.96 0.26 2.58 0.39 0.50
SDS-4 ≥ 10 0.78 0.71 0.96 0.23 2.64 0.38 0.48
SDS-4 ≥ 11 0.75 0.76 0.97 0.23 3.14 0.32 0.51
SDS-4 ≥ 12 0.73 0.79 0.97 0.22 3.52 0.28 0.52
SDS-4 ≥ 13 0.71 0.81 0.97 0.21 3.65 0.27 0.51
Table 7
Operational characteristics of the SDS for moderate depressive symptoms
Cut-off score SE SP + PV - PV + LR - LR J
SDS-4 ≥ 11 0.84 0.57 0.80 0.62 1.93 0.52 0.40
SDS-4 ≥ 12 0.81 0.60 0.81 0.60 2.04 0.49 0.42
SDS-4 ≥ 13 0.80 0.63 0.82 0.59 2.13 0.47 0.42
SDS-4 ≥ 14 0.76 0.66 0.83 0.57 2.27 0.44 0.43
SDS-4 ≥ 15 0.74 0.68 0.83 0.55 2.33 0.43 0.42
SDS-4 ≥ 16 0.71 0.73 0.85 0.54 2.63 0.38 0.44
Table 8
Operational characteristics of the SDS for moderate severe depressive symptoms
Cut-off score SE SP + PV - PV + LR - LR J
SDS-4 ≥ 14 0.83 0.53 0.57 0.80 1.75 0.57 0.36
SDS-4 ≥ 15 0.81 0.55 0.57 0.79 1.79 0.56 0.36
SDS-4 ≥ 16 0.79 0.60 0.60 0.79 1.97 0.51 0.39
SDS-4 ≥ 17 0.76 0.63 0.61 0.77 2.02 0.49 0.38
SDS-4 ≥ 18 0.72 0.66 0.62 0.76 2.12 0.47 0.38
SDS-4 ≥ 19 0.70 0.69 0.63 0.75 2.26 0.44 0.39
Table 9
Operational characteristics of the SDS for moderate severe depressive symptoms
Cut-off score SE SP + PV - PV + LR - LR J
SDS-4 ≥ 18 0.81 0.54 0.21 0.95 1.75 0.57 0.34
SDS-4 ≥ 19 0.81 0.57 0.22 0.95 1.89 0.53 0.38
SDS-4 ≥ 20 0.75 0.62 0.23 0.94 1.95 0.51 0.37
SDS-4 ≥ 21 0.72 0.64 0.23 0.94 2.00 0.50 0.36
SDS-4 ≥ 22 0.71 0.67 0.24 0.94 2.17 0.46 0.38
SDS-4 ≥ 23 0.67 0.71 0.26 0.94 2.30 0.44 0.38
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The predictive validity (ROC analysis) of the SDS-4 to 
discriminate for depression was good, with an optimal cut-off 
score (according to Youden’s index) of 19. Although a cut-
off of 16 provided better sensitivity (0.77), this cut point could 
lead to a higher rate of false positives (39% in our sample; 
specifi city=0.61). Several cut-off scores yielded similar sensitivity 
and specifi city results for mild, moderate, moderately severe, and 
severe depressive symptoms; however, the most sensitive cut-off 
points were, respectively, 9, 14, 16 and 19, although all of these cut 
points also resulted in a high rate of false positives (ranging from 
43 to 31%, respectively). Although the SDS-4 is more accurate 
to detect mild depressive symptoms, its capacity to discriminate 
for the other levels of depression was acceptable. Consequently, 
clinicians should select the cut-off scores that most closely align 
with their clinical objectives (e.g., greater sensitivity versus higher 
specifi city). In short, this new tool could be highly useful in the 
PC setting, allowing a range of different health care professionals 
to work together to accurately identify patients with depression-
related disability to offer them the best treatment possible in a 
timely manner (Muñoz-Navarro et al., 2017b). 
This study has several limitations, the most being the lack of 
a gold standard (i.e., structured clinical interview) to defi nitively 
diagnose depression. However, previous validity of the Spanish 
version of the PHQ-9 in PC patients in Spain has shown that the 
PHQ-9 is reliable when compared to the gold standard (Muñoz-
Navarro et al., 2017a). In this study, the diagnostic algorithm of 
the PHQ-9 yielded good sensitivity and specifi city rates (0.88 
and 0.80), which support the use of the PHQ-9 for the present 
work. Another study limitation is that the convergent validity 
of the SDS-4 was not assessed, which should be done in future 
studies. 
To conclude, the present study shows that adding an additional 
item— perceived stress (PS)—to create the SDS-4 improves the 
psychometric properties of this very brief tool. Based on these 
fi ndings, the SDS-4 appears to offer clinicians a reliable tool to 
assess disability in patients with major depression.
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